LNCRNA FOXD1-AS1 ACTS AS A POTENTIAL ONCOGENIC BIOMARKER IN GLIOMA

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Gao, Yuan-Feng;Liu, Jun-Yan;Mao, Xiao-Yuan;He, Zheng-Wen;Zhu, Tao;...

通讯作者：

Liu, ZQ

作者机构：

[Mao, Xiao-Yuan; Zhu, Tao; Yin, Ji-Ye; Zhang, Wei; Liu, Zhao-Qian; Wang, Zhi-Bin; Zhou, Hong-Hao; Gao, Yuan-Feng; Li, Xi] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China.

[Mao, Xiao-Yuan; Zhu, Tao; Yin, Ji-Ye; Zhang, Wei; Wang, Zhi-Bin; Liu, Zhao-Qian; Zhou, Hong-Hao; Gao, Yuan-Feng; Li, Xi] Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.

[Gao, Yuan-Feng] Hunan Univ Chinese Med, Dept Pharm, Hosp 1, Changsha, Hunan, Peoples R China.

[Liu, Jun-Yan] Univ South China, Dept Orthopaed, Affiliated Hosp 1, Hengyang, Peoples R China.

[He, Zheng-Wen] Cent S Univ, Dept Neurosurg, Affiliated Canc Hosp, XiangYa Sch Med, Changsha, Hunan, Peoples R China.

通讯机构：

[Liu, ZQ ] C

Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China.

语种：

英文

关键词：

eIF5a;glioma;lncRNA FOXD1-AS1;lncRNAs;miR-339/342

期刊：

CNS Neuroscience & Therapeutics

ISSN：

1755-5930

年：

2020

卷：

期：

页码：

66-75

DOI：

10.1111/cns.13152

基金类别：

Funding information This study was supported by the National Key Research and Development Programs (2016YFC1306900, 2016YFC0905002), National Natural Science Foundation of China (81573463, 81573508 and 81803641), Open Foundation of Innovative Platform in Colleges and University of Hunan Province ([2015]54), Clinical Research Fund of Peking University Unamed-Central South University Xiangya Hospital (xywm2015I16), and The Strategy-Oriented Special Project of Central South University in China (ZLXD2017003).

机构署名：

本校为其他机构

院系归属：

第一中医临床学院

药学院

摘要：

AIMS: Altered activities of long noncoding RNAs (lncRNAs) have been associated with cancer development, and lncRNA FOXD1-AS1 (FOXD1-AS1) is the antisense transcript of the gene encoding for FOXD1, known for its role as an oncogene in several tumor types including glioma. However, the role of FOXD1-AS1 in the differentiation and progression of glioma is not well known. METHODS: Expression profile chip and qPCR were used to screen and identify FOXD1-AS1. Glioma cells were transfected with siRNA or eukaryotic expression vector to observe FOXD1-AS1 function in vitro and in vivo. Dual luciferase re...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

LNCRNA FOXD1-AS1 ACTS AS A POTENTIAL ONCOGENIC BIOMARKER IN GLIOMA

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问